Literature DB >> 3609042

Spontaneous course of aortic valve disease.

J Turina, O Hess, F Sepulcri, H P Krayenbuehl.   

Abstract

The fate of patients with aortic valve disease of varying degrees of severity and the relationship between symptoms and haemodynamic status have been studied in 190 adults undergoing cardiac catheterization during the last two decades. During the follow-up period, 41 patients died and 86 underwent aortic valve replacement; these two events were the endpoints for the calculation of 'event-free' cumulative survival. First-year survival in haemodynamically severe disease was 60% in aortic stenosis and 96% in aortic regurgitation; in moderate and mild disease (in the absence of coronary artery disease) first-year survival was 100% in both groups. After 10 years, 9% of those with haemodynamically severe aortic stenosis and 17% of those with severe regurgitation were event-free, in contrast to 35% and 22%, respectively, of those with moderate changes and 85% and 75%, respectively, of those with mild abnormalities. In the presence of haemodynamically severe disease, 66% of the patients with stenosis and 14% of those with regurgitation were severely symptomatic (history of heart failure, syncope or New York Heart Association class III and IV); 23% of patients with moderate stenosis and 14% with moderate regurgitation were also severely symptomatic. Only 40% of those with disease that was severe both haemodynamically and symptomatically with either stenosis or regurgitation survived the first two years; only 12% in the stenosis group and none in the regurgitation group were event-free at 5 years. Patients with haemodynamically severe aortic stenosis who had few or no symptoms had a 100% survival at 2 years; the comparable figure for the aortic regurgitation group was 94%; 75% of the patients in the stenosis group and 65% in the regurgitation group were event-free at 5 years. In the moderate or mild stenosis and regurgitation groups there was no mortality within the first 2 years in the absence of coronary artery disease, regardless of symptomatic status. Haemodynamically and symptomatically severe aortic stenosis and regurgitation have a very poor prognosis and require immediate valve surgery. Asymptomatic and mildly symptomatic patients with haemodynamically severe aortic stenosis are at low risk and surgical treatment can be postponed until marked symptoms appear without a significant risk of sudden death. In severe aortic regurgitation, the decision for surgery should depend not only on symptoms but should be considered in patients with few or no symptoms because of risk of sudden death. In the absence of coronary artery disease, moderate aortic valve disease does not require valve operation for prognostic reasons.

Entities:  

Mesh:

Year:  1987        PMID: 3609042     DOI: 10.1093/oxfordjournals.eurheartj.a062307

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  51 in total

Review 1.  Should patients with asymptomatic mild or moderate aortic stenosis undergoing coronary artery bypass surgery also have valve replacement for their aortic stenosis?

Authors:  S H Rahimtoola
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

2.  Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis: assessment using 11C-acetate positron emission tomography.

Authors:  Masanao Naya; Satoru Chiba; Hiroyuki Iwano; Satoshi Yamada; Chietsugu Katoh; Osamu Manabe; Keiichiro Yoshinaga; Yoshiro Matsui; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

3.  Incremental prognostic role of left atrial reservoir strain in asymptomatic patients with moderate aortic stenosis.

Authors:  Andrea Sonaglioni; Gian Luigi Nicolosi; Elisabetta Rigamonti; Michele Lombardo
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-05       Impact factor: 2.357

Review 4.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 5.  Management of asymptomatic aortic stenosis: masterly inactivity but cat-like observation.

Authors:  J C Vaile; M J Griffith
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

Review 6.  Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies.

Authors:  Ziad Sergie; Thierry Lefèvre; Eric Van Belle; Socrates Kakoulides; Usman Baber; Efthymios N Deliargyris; Roxana Mehran; Eberhard Grube; Jochen Reinöhl; George D Dangas
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

7.  Transcatheter aortic valve implantation (TAVI) versus sutureless aortic valve replacement (SUAVR) for aortic stenosis: a systematic review and meta-analysis of matched studies.

Authors:  Nelson Wang; Yi-Chin Tsai; Natasha Niles; Vakhtang Tchantchaleishvili; Marco Di Eusanio; Tristan D Yan; Kevin Phan
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

8.  Long axis excursion in aortic stenosis.

Authors:  S Takeda; H Rimington; N Smeeton; J Chambers
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

9.  Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly.

Authors:  Stefan Sack; Philipp Kahlert; Sasan Khandanpour; Christoph Naber; Sebastian Philipp; Stefan Möhlenkamp; Burkhard Sievers; Hagen Kälsch; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2008-04-03       Impact factor: 5.460

10.  "Not clinically indicated": patients' interests or resource allocation?

Authors:  T Hope; D Sprigings; R Crisp
Journal:  BMJ       Date:  1993-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.